We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-21.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.78B
AUM Growth
-$2.41B
Cap. Flow
+$423M
Cap. Flow %
5.44%
Top 10 Hldgs %
19.24%
Holding
1,167
New
181
Increased
433
Reduced
358
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 22.86%
2 Healthcare 16.25%
3 Financials 14.24%
4 Consumer Discretionary 10.76%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUMP icon
976
ProPetro Holding
PUMP
$1.33B
$60K ﹤0.01%
+23,912
New +$192K
OTIC
977
DELISTED
Otonomy, Inc.
OTIC
$60K ﹤0.01%
30,263
-38,378
-56% -$118K
TUES
978
DELISTED
Tuesday Morning Corp
TUES
$55K ﹤0.01%
+96,000
New +$137K
RMNI icon
979
Rimini Street
RMNI
$454M
$54K ﹤0.01%
13,101
-44,473
-77% -$198K
SONM icon
980
DNA X Inc
SONM
$4.84M
$53K ﹤0.01%
42
-2
-5% -$9.58K
HIL
981
DELISTED
Hill International, Inc. Common Stock
HIL
$47K ﹤0.01%
32,417
-26,243
-45% -$74.9K
MRKR icon
982
Marker Therapeutics
MRKR
$18.7M
$43K ﹤0.01%
2,273
-12,555
-85% -$320K
KTCC icon
983
Key Tronic
KTCC
$43.4M
$41K ﹤0.01%
+14,005
New +$71.1K
SHLO
984
DELISTED
Shiloh Industries Inc
SHLO
$40K ﹤0.01%
32,089
-8,099
-20% -$23K
LEAF
985
DELISTED
Leaf Group Ltd.
LEAF
$39K ﹤0.01%
29,014
-40,909
-59% -$111K
BCRX icon
986
BioCryst Pharmaceuticals
BCRX
$2.35B
$36K ﹤0.01%
18,100
-2,098,317
-99% -$5.78M
LITS
987
Lite Strategy Inc
LITS
$33.6M
$34K ﹤0.01%
1,057
-9,710
-90% -$388K
BKD icon
988
Brookdale Senior Living
BKD
$3.49B
$31K ﹤0.01%
10,010
-320,597
-97% -$1.87M
PDLI
989
DELISTED
PDL BioPharma, Inc.
PDLI
$29K ﹤0.01%
+10,312
New +$33.2K
CHRA
990
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$26K ﹤0.01%
1,534
-2,306
-60% -$53.7K
FPRX
991
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$26K ﹤0.01%
11,415
-349,884
-97% -$1.48M
CMRX
992
DELISTED
Chimerix, Inc.
CMRX
$19K ﹤0.01%
12,920
-563,718
-98% -$987K
VOLT
993
DELISTED
Volt Information Sciences, Inc.
VOLT
$13K ﹤0.01%
16,558
-13,627
-45% -$26.8K
ACRS icon
994
Aclaris Therapeutics
ACRS
$743M
-111,166
Closed -$210K
AFL icon
995
Aflac
AFL
$64.8B
-4,322
Closed -$229K
AIRG icon
996
Airgain
AIRG
$72.8M
-10,850
Closed -$116K
ALEX
997
DELISTED
Alexander & Baldwin
ALEX
-20,638
Closed -$433K
AMPY icon
998
Amplify Energy
AMPY
$155M
-74,138
Closed -$490K
ANGO icon
999
AngioDynamics
ANGO
$610M
-35,597
Closed -$570K
APAM icon
1000
Artisan Partners
APAM
$2.82B
-30,436
Closed -$984K

Similar funds

Jacobs Levy Equity Management's Q1 2020 Portfolio in Review

As of Q1 2020, Jacobs Levy Equity Management held 1,167 positions worth $7.78B, down 24% from $10.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Jacobs Levy Equity Management deployed $423M of net new capital in Q1 2020, opening 181 new positions and adding to 433 existing holdings. Its largest new stake was Gaming and Leisure Properties: 979,767 shares worth $27.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Amazon, an estimated $60.9M trimmed.

  • Jacobs Levy Equity Management's largest Q1 2020 buy was Gaming and Leisure Properties: 979,767 shares worth $27.1M.
  • Jacobs Levy Equity Management added most to Synchrony in Q1 2020, an estimated $56.1M increase.
  • Jacobs Levy Equity Management's biggest Q1 2020 reduction was Amazon, cutting an estimated $60.9M.
  • Jacobs Levy Equity Management fully exited Willis Towers Watson in Q1 2020, selling an estimated $49.9M.
  • Jacobs Levy Equity Management's ten largest holdings make up 19% of its $7.78B portfolio in Q1 2020.
  • Jacobs Levy Equity Management opened 181 new positions and closed 174 in Q1 2020.
  • Jacobs Levy Equity Management's portfolio value fell 24% quarter-over-quarter to $7.78B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2020, filed 15 May 2020.